Cargando…
Naloxone Use by Emergency Medical Services During the COVID-19 Pandemic: A National Survey
OBJECTIVES: The COVID-19 epidemic in the United States has hit in the midst of the opioid overdose crisis. Emergency medical services (EMS) clinicians may limit their use of intranasal naloxone due to concerns of novel coronavirus infection. We sought to determine changes in overdose events and nalo...
Autores principales: | Cone, David C., Bogucki, Sandy, Burns, Kevin, D’Onofrio, Gail, Hawk, Kathryn, Joseph, Daniel, Fiellin, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647432/ https://www.ncbi.nlm.nih.gov/pubmed/33031212 http://dx.doi.org/10.1097/ADM.0000000000000746 |
Ejemplares similares
-
Emergency department‐initiated buprenorphine protocols: A national evaluation
por: Guo, Clara Z., et al.
Publicado: (2021) -
Emergency department screening and interventions for substance use disorders
por: Hawk, Kathryn, et al.
Publicado: (2018) -
Correction to: Emergency department screening and interventions for substance use disorders
por: Hawk, Kathryn, et al.
Publicado: (2019) -
Incidence of Precipitated Withdrawal During a Multisite Emergency Department–Initiated Buprenorphine Clinical Trial in the Era of Fentanyl
por: D’Onofrio, Gail, et al.
Publicado: (2023) -
Trends in the Use of Buprenorphine in US Emergency Departments, 2002-2017
por: Rhee, Taeho Greg, et al.
Publicado: (2020)